Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Sales | 170 | 134 | 187 | 69 | 804 |
| Cost of Goods | N/A | N/A | N/A | N/A | 560 |
| Gross Profit | 170 | 134 | 187 | 69 | 270 |
| Operating Expenses | 969 | 954 | 1,102 | 1,173 | 2,000 |
| Operating Income | -799 | -820 | -915 | -1,104 | -1,196 |
| Interest Expense | 121 | 113 | 87 | 82 | 140 |
| Other Income | -23 | -26 | -40 | -71 | 6 |
| Pre-tax Income | -943 | -959 | -1,042 | -1,256 | -1,330 |
| Net Income Continuous | -944 | -959 | -1,042 | -1,256 | -1,311 |
| Net Income | $-944 | $-959 | $-1,042 | $-2,316 | $-1,311 |
| EPS Basic Total Ops | -0.22 | -0.22 | -0.24 | -0.54 | -0.95 |
| EPS Basic Continuous Ops | -0.22 | -0.22 | -0.24 | -0.29 | -0.92 |
| EPS Diluted Total Ops | -0.22 | -0.22 | -0.24 | -0.54 | -0.95 |
| EPS Diluted Continuous Ops | -0.22 | -0.22 | -0.24 | -0.29 | -0.92 |
| EBITDA(a) | $-701 | $-718 | $-825 | $-1,000 | $-1,056 |